• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, March 29, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Salk neurobiologist receives NIH Director’s New Innovator award

Bioengineer.org by Bioengineer.org
January 28, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Salk Institute

LA JOLLA – (Oct. 5, 2017) Salk Institute Assistant Professor Eiman Azim has been named an NIH Director's New Innovator for 2017 as part of the National Institutes of Health's High-Risk, High-Reward Research Program. The award provides $1.5 million for a 5-year project during which Azim will explore how the nervous system controls dexterous movements.

The NIH Director's New Innovator award is designed specifically to support a small group of creative scientists at an early stage of their career with an emphasis on innovative, high-impact projects, according to the NIH website.

"Eiman employs the most cutting-edge laboratory and imaging technologies to probe how neural circuits achieve motor control," says Salk President Elizabeth Blackburn. "We are thrilled that his research, which has tremendous potential for life-changing insights into movement disorders, has been recognized with a prestigious NIH Director's New Innovator Award."

Dexterous movements of limbs and fingers are critical motor functions often affected by neurodegenerative disease and injury. Azim's research seeks to lay the fundamental groundwork for understanding how the nervous system achieves this complex and coordinated behavior, progress that could ultimately lead to more effective treatments. Azim, who is a member of Salk's Molecular Neurobiology Laboratory, uses a multidisciplinary approach to identify how neural circuits control skilled movements, taking advantage of modern techniques in neurobiology, genetics and computer vision to investigate how diverse neural pathways are involved in different aspects of motor control.

"I am tremendously honored to have been selected for this award," says Azim. "This funding allows us to think big and try to tackle some of the more difficult challenges that we face. For example, we hope to develop new ways to define and quantify fine movements, providing the behavioral resolution that we need to tease apart the neural circuits that establish such impressive motor output."

Azim was also recently named a Pew Scholar, Searle Scholar and Kathryn W. Davis Aging Brain Scholar. Additionally, he is a recipient of an NIH Pathway to Independence award.

###

About the Salk Institute for Biological Studies:

Every cure has a starting point. The Salk Institute embodies Jonas Salk's mission to dare to make dreams into reality. Its internationally renowned and award-winning scientists explore the very foundations of life, seeking new understandings in neuroscience, genetics, immunology, plant biology and more. The Institute is an independent nonprofit organization and architectural landmark: small by choice, intimate by nature and fearless in the face of any challenge. Be it cancer or Alzheimer's, aging or diabetes, Salk is where cures begin. Learn more at: salk.edu.

Media Contact

Salk Communications
[email protected]
858-453-4100
@salkinstitute

Home

Share12Tweet7Share2ShareShareShare1

Related Posts

Cutaneous Lesion Location: Key to Head Injury Risk?

March 27, 2026
Biochar Boosts Forest Resilience Against Acid Rain by Restoring Essential Soil Nitrogen

Biochar Boosts Forest Resilience Against Acid Rain by Restoring Essential Soil Nitrogen

March 27, 2026

Two Salk Scientists Honored as 2025 AAAS Fellows

March 27, 2026

Starburst Winds Drain Supernova Energy Quickly

March 26, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1004 shares
    Share 397 Tweet 248
  • Uncovering Functions of Cavernous Malformation Proteins in Organoids

    54 shares
    Share 22 Tweet 14
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

In-Sensor Cryptography Links Physical Process to Digital Identity

Can Psychosocial Factors Influence Cancer Risk?

Depression Factors in Elderly: Pre vs. Post-COVID Analysis

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.